Next generation sequencing with copy number variant detection expands the phenotypic spectrum of HSD17B4-deficiency

Daniel S Lieber, Steven G Hershman, Nancy G Slate

  • 1Ataxia Unit, Cognitive Behavioral Neurology Unit, Laboratory for Neuroanatomy and Cerebellar Neurobiology, Department of Neurology, Massachusetts General Hospital & Harvard Medical School, Boston, MA 02114 USA, jschmahmann@partners.org

BMC Medical Genetics
|March 8, 2014
PubMed

Insights

D-bifunctional protein deficiency, caused by HSD17B4 mutations, is a severe disorder. This case reveals a new male phenotype including infertility, expanding the known spectrum of this peroxisomal fatty acid oxidation disorder.

Area of Science:

  • Genetics
  • Biochemistry
  • Neurology

Background:

  • D-bifunctional protein deficiency, caused by HSD17B4 mutations, is a severe infantile-onset peroxisomal fatty acid oxidation disorder.
  • Previous reports linked HSD17B4 mutations to Perrault syndrome in adolescent females with ovarian dysgenesis, hearing loss, and ataxia.

Observation:

  • An adult male presented with cerebellar ataxia, peripheral neuropathy, hearing loss, and azoospermia.
  • Genetic testing, including exome sequencing, initially failed to identify a cause.
  • Copy number variant analysis revealed a heterozygous deletion in HSD17B4 compounded with a missense variant.

Findings:

  • The patient had a heterozygous 12 kb deletion of HSD17B4 exons 10-13 and a rare missense variant (p.A196V).
  • Biochemical findings showed mildly elevated pristanic:phytanic and arachidonic:docosahexaenoic acid ratios, indicating peroxisomal dysfunction.
  • This represents the first reported male case of HSD17B4-deficiency with infertility.

Implications:

  • This case expands the phenotypic spectrum of HSD17B4-deficiency to include male infertility.
  • It highlights the potential interplay between mitochondrial and peroxisomal function in HSD17B4-deficiency and Perrault syndrome.
Abstract

Related Concept Videos

Comparing Copy Number Variations and SNPs02:26

Comparing Copy Number Variations and SNPs

Sequencing of the human genome has opened up several best-kept secrets of the genome. Scientists have identified thousands of genome variations that exist within a population. These variations can be a single nucleotide or a larger chromosomal variation.
Copy number variations or CNVs are the structural variations that cover more than 1kb of DNA sequence. The single nucleotide polymorphism (SNP), on the other hand, is a single nucleotide change or a point mutation that is found in more than 1%...
11.6K
Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
12.6K
Single Nucleotide Polymorphisms-SNPs01:05

Single Nucleotide Polymorphisms-SNPs

A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
14.6K
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
121
Incomplete Dominance01:43

Incomplete Dominance

Gregor Mendel's work (1822 - 1884) was primarily focused on pea plants. Through his initial experiments, he determined that every gene in a diploid cell has two variants called alleles inherited from each parent. He suggested that amongst these two alleles, one allele is dominant in character and the other recessive. The combination of alleles determines the phenotype of a gene in an organism.
19.0K
Principles of Pharmacogenetics: Types of Genetic Variants01:27

Principles of Pharmacogenetics: Types of Genetic Variants

The human genome is over 99.9% identical between individuals, yet genetic differences exist at millions of bases. The human genome contains approximately 3 million variant positions per individual, many of which are heterozygous, contributing to genetic diversity and individual traits. Genetic variations include single-nucleotide polymorphisms (SNPs), insertions, deletions, and copy number variations (CNVs).SNPs, the most common variation, involve single-base changes in DNA. These can be...
138